Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AzentaLTS:0HQ1 +1.82%72 Quick Ratio is 2.21 as of Jun. 2026, which is 12% below its 10-year median of 2.50. GuruFocus rates LTS:0HQ1 with a GF Score™ of 72/100 and a GF Value™ of $51.26 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 851 Medical Devices & Instruments companies, Azenta ranks better than 57.23% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Azenta's quick ratio for the quarter that ended in Jun. 2026 was 2.21.
Azenta has a quick ratio of 2.21. It generally indicates good short-term financial strength.
The historical rank and industry rank for Azenta's Quick Ratio or its related term are showing as below:
LTS:0HQ1'
s Quick Ratio Range Over the Past 10 Years
Min: 1.67 Med: 2.5 Max: 12.79
Current: 2.21
During the past 13 years, Azenta's highest Quick Ratio was 12.79. The lowest was 1.67. And the median was 2.50.
LTS:0HQ1's Quick Ratio is ranked better than 57.23% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 1.85
vs LTS:0HQ1: 2.21
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Azenta Quick Ratio Related Terms
Azenta Quick Ratio Historical Data
* Premium members only.
The historical data trend for Azenta's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0HQ1 vs KMTS, STAA, BLFS: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Azenta's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azenta Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Azenta's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Azenta's Quick Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azenta (LTS:0HQ1) has a Quick Ratio of 2.21 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Azenta and its competitors. This is 12% below median its historical median of 2.50. Over the past decade, Azenta's Quick Ratio has ranged from 1.67 to 12.79. According to the industry distribution chart, Azenta ranks #364 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 42.8%.
Is Azenta's Quick Ratio too high?
Azenta's current Quick Ratio of 2.21 is 12% below median its 10-year median of 2.50. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 12.79. The Medical Devices & Instruments industry median Quick Ratio is 1.85. Azenta's value of 2.21 is 19.5% above this industry median. Based on the distribution chart, Azenta ranks #364 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Azenta has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Quick Ratio compare to KMTS and STAA?
According to the Medical Devices & Instruments industry distribution chart, Azenta ranks #364 out of 851 companies for Quick Ratio. This puts Azenta in the upper half of its industry. The industry median Quick Ratio is 1.85. Azenta's value of 2.21 is 19.5% above this benchmark. Historically, Azenta's own Quick Ratio has ranged from 1.67 to 12.79 over the past decade. While the company's 10-year median is 2.50 vs. the industry median of 1.85, Azenta has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.85, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azenta's current Quick Ratio of 2.21 is 19.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Azenta and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azenta's current Quick Ratio is 2.21, which is 12% below median its own 10-year median of 2.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (LTS:0HQ1) is currently considered Significantly Undervalued. The stock's GF Value™ is $51.26, compared to a current price of $32.82 — trading 36% below its estimated fair value. The current Quick Ratio is 2.21, which is 12% below median its 10-year median of 2.50 and 19.5% above the Medical Devices & Instruments industry median of 1.85. Azenta's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Azenta (LTS:0HQ1), the current Quick Ratio is 2.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azenta (LTS:0HQ1) Overvalued in 2026?
Based on GuruFocus' analysis, Azenta stock appears to be undervalued.
The current stock price of $32.82 is trading 36% below its estimated GF Value™ of $51.26.
GuruFocus considers Azenta to be Significantly Undervalued.
Key valuation signals for LTS:0HQ1:
Quick Ratio: 2.21 (12% below median its 10-year median of 2.50)
GF Value™: $51.26 vs. price of $32.82 (36% below fair value)
Industry Position: 19.5% above the Medical Devices & Instruments median (#364 of 851)
No single metric tells the full story. See the LTS:0HQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
72GF Score
Get the complete analysis for LTS:0HQ1
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HQ1 has been successfully added to your 
